Hematopoietic growth factors

被引：34
作者：
Bociek, RG
Armitage, JO
机构：
[1] University of Ottawa, Department of Medicine, Division of Medical Oncology, Ottawa, Ont.
[2] Department of Medicine, Univ. of Nebraska Medical Center, Omaha, NE
来源：
CA-A CANCER JOURNAL FOR CLINICIANS | 1996年 / 46卷 / 03期
关键词：
D O I：
10.3322/canjclin.46.3.165
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Over the past 10 years, the availability of pharmacologic quantities of hematopoietic growth factors has opened many avenues of study in basic science and clinical investigation. Pharmacologic agents that accelerate hematopoietic recovery obviously have the potential to improve selected therapeutic and supportive care aspects of cancer medicine. This article reviews important clinical and scientific aspects of hematopoietic growth factors, with an emphasis on their present-day use in the care of cancer patients.
引用
收藏
页码：165 / +
页数：1
相关论文
共 138 条
[11]   RETRACTED: HIGH-DOSE CHEMOTHERAPY WITH HEMATOPOIETIC RESCUE AS PRIMARY-TREATMENT FOR METASTATIC BREAST-CANCER - A RANDOMIZED TRIAL (Retracted article. See vol. 19, pg. 2973, 2001) [J].
BEZWODA, WR ;
SEYMOUR, L ;
DANSEY, RD .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (10) :2483-2489
[12]  
BOMMER J, 1988, LANCET, V2, P406
[13]   DOSE-RESPONSE EFFECT OF ADJUVANT CHEMOTHERAPY IN BREAST-CANCER [J].
BONADONNA, G ;
VALAGUSSA, P .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 304 (01) :10-15
[14]   EFFECT OF RECOMBINANT HUMAN GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR ON HEMATOPOIETIC RECONSTITUTION AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION [J].
BRANDT, SJ ;
PETERS, WP ;
ATWATER, SK ;
KURTZBERG, J ;
BOROWITZ, MJ ;
JONES, RB ;
SHPALL, EJ ;
BAST, RC ;
GILBERT, CJ ;
OETTE, DH .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (14) :869-876
[15]   GENE-MARKING TO TRACE ORIGIN OF RELAPSE AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION [J].
BRENNER, MK ;
RILL, DR ;
MOEN, RC ;
KRANCE, RA ;
MIRRO, J ;
ANDERSON, WF ;
IHLE, JN .
LANCET, 1993, 341 (8837) :85-86
[16]   RETRACTED: RECONSTITUTION OF HEMATOPOIESIS AFTER HIGH-DOSE CHEMOTHERAPY BY AUTOLOGOUS PROGENITOR CELLS GENERATED EX-VIVO (RETRACTED ARTICLE. SEE VOL 345, PG 64, 2001) [J].
BRUGGER, W ;
HEIMFELD, S ;
BERENSON, RJ ;
MERTELSANN, R ;
KANZ, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (05) :283-287
[17]  
BRUGGER W, 1994, BLOOD, V84, pA395
[18]  
BUESCHER ES, 1988, J INFECT DIS, V158, P1140
[19]  
CANNISTRA SA, 1989, LEUKEMIA, V3, P328
[20]   RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR (RHUMGDF), A LIGAND FOR C-MPL, PRODUCES FUNCTIONAL HUMAN PLATELETS IN-VITRO [J].
CHOI, ES ;
HOKOM, M ;
BARTLEY, T ;
LI, YS ;
OHASHI, H ;
KATO, T ;
NICHOL, JL ;
SKRINE, J ;
KNUDTEN, A ;
CHEN, J ;
HORNKOHL, A ;
GRAMPP, G ;
SLEEMAN, L ;
COLE, S ;
TRAIL, G ;
HUNT, P .
STEM CELLS, 1995, 13 (03) :317-322
12345678910